{"organizations": [], "uuid": "d1737d4057fcf9735c9920ab8a7ca28132a14f44", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-WV073_LUXTUR_SOC_20180102215146.jpg", "site_section": "http://www.wsj.com/xml/rss/3_7014.xml", "section_title": "WSJ.com: US Business", "url": "https://www.wsj.com/articles/drug-firm-spark-therapeutics-will-charge-850-000-for-vision-loss-gene-therapy-1514986201", "country": "US", "domain_rank": 387, "title": "Drug Firm Spark Therapeutics Will Charge $850,000 for Vision-Loss Gene Therapy", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-03T15:30:00.000+02:00", "replies_count": 0, "uuid": "d1737d4057fcf9735c9920ab8a7ca28132a14f44"}, "author": "Peter Loftus", "url": "https://www.wsj.com/articles/drug-firm-spark-therapeutics-will-charge-850-000-for-vision-loss-gene-therapy-1514986201", "ord_in_thread": 0, "title": "Drug Firm Spark Therapeutics Will Charge $850,000 for Vision-Loss Gene Therapy", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "luxturna", "sentiment": "none"}], "organizations": [{"name": "vision-loss gene therapy spark therapeutics inc.", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Spark Therapeutics Inc. said it would charge $850,000 a patient for a pioneering new treatment for a hereditary form of vision loss—below the $1 million price tag the company had considered, but still a milestone for ever-rising drug prices in the U.S.\n\nTo address concerns about the cost of the drug, Luxturna, Spark said it is offering alternative payment arrangements to health insurers, including partial refunds if a patient’s vision doesn’t improve significantly after treatment. The company also is seeking U.S. government...  ", "external_links": [], "published": "2018-01-03T15:30:00.000+02:00", "crawled": "2018-01-03T16:06:06.012+02:00", "highlightTitle": ""}